The digital press release with multimedia content can be accessed here: Basel, March 06, 2017 - Novartis announced today a new analysis showing that moderate-to-severe psoriasis patients treated with ...
The Food and Drug Administration (FDA) has approved Cosentyx (secukinumab) injections for treating various inflammatory conditions in adults and, in some cases, children. Cosentyx may treat moderate ...
EAST HANOVER, N.J., Jan. 15, 2016 /PRNewswire/ -- Novartis announced today that the US Food and Drug Administration (FDA) has approved Cosentyx® (secukinumab) for two new indications - the treatment ...
Please note Chef Michelle Bernstein is a COSENTYX® (secukinumab) patient and has been compensated for her time. Continue reading for Important Safety Information and a link to the full Prescribing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback